Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
Next >
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
Biotechnology
US: News
Walmart Inc
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Health insurance
Prescription drugs
Pharmaceuticals
From
CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
October 13, 2023
Tags
Business News
US: News
Biotechnology
From
CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 11, 2023
Tickers
BIRK
EVS
MSFT
NVO
Tags
NVO
TSLA
News
From
Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
Tags
Investing
Business News
Walmart Inc
From
CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
Tags
Exxon Mobil Corp
Market Insider
Fresenius Medical Care AG & Co KGaA
From
CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
October 11, 2023
Tags
Take/Two Interactive Software Inc
Novo Nordisk A/S
Exxon Mobil Corp
From
CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
October 11, 2023
Tags
Earnings
Novo Nordisk A/S
Europe Markets
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Biotech and Pharmaceuticals
Business
Stock markets
From
CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
October 10, 2023
Tags
CNBC Investing Club: Newsletter
Harley/Davidson Inc
Novo Nordisk A/S
From
CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
October 05, 2023
Tags
Health & Science
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
October 05, 2023
Tags
Floor & Decor Holdings Inc
Airbnb Inc
McCormick & Company Inc
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
October 01, 2023
Tags
Health & Science
PepsiCo Inc/
Novo Nordisk A/S
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Breaking news
Companies
Novo Nordisk A/S
From
CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
September 29, 2023
Tags
Biotechnology
US: News
Business News
From
CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
Tags
Business News
Biotechnology
US: News
From
CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
September 19, 2023
Tags
Companies
Breaking news
Lawsuits
From
CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
September 11, 2023
Tags
Investing
Investment strategy
Breaking News: Markets
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Business News
Addiction and substance abuse
US: News
From
CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
Tags
Amgen Inc
CNBC Global CFO Council
Obesity
From
CNBC.com News
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
September 07, 2023
Tags
Life Sciences
Health care industry
Pharmaceuticals
From
CNBC.com News
Stocks making the biggest moves premarket: Enbridge, Roku, Gitlab and more
September 06, 2023
Tags
Southwest Airlines Co
Resmed Inc
C3 ai Inc
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug launches in the UK
September 04, 2023
Tags
Europe News
Biotech and Pharmaceuticals
Europe Markets
From
CNBC.com News
Weight loss drugmaker Novo Nordisk vies to become Europe's most valuable company, toppling LVMH
September 01, 2023
Tags
Europe News
Business
Europe Markets
From
CNBC.com News
5 things to know before the stock market opens Friday
September 01, 2023
Tags
Technology
Lululemon Athletica Inc
Politics
From
CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Law and Regulation
Biotechnology
US: News
From
CNBC.com News
Wegovy helps reduce heart failure symptoms in obese people, study says
August 25, 2023
Tags
Business News
Biotechnology
US: News
From
CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
Tags
Kroger Co
Retail
Business News
From
CNBC.com News
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
August 17, 2023
Tags
Eli Lilly and Co
Biotech and Pharmaceuticals
Business
From
CNBC.com News
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.